Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

PaperCitations, authors & open-access status

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 129 citations, 2022 year and bronze oa status.

129
Citations
2022
Year
bronze
OA Status

Related on ScholarIQ

Thanh Tran
Author
The Lancet Respiratory Medicine
Journal
SARS-CoV-2 and COVID-19 Research
Topic
SARS-CoV-2 and COVID-19 Research
Topic
COVID-19 Clinical Research Studies
Topic
Long-Term Effects of COVID-19
Topic
470M+ articles · free account